Padeliporfin VTP (brand name Tookad) has previously been approved by the European Union, Israel, and Mexico as a treatment for low-risk prostate cancer, following demonstration of significant clinical ...

Following this standard treatment regimen, the rodents develop recurrent tumors, establishing what is referred to as an ...